Dr. Joel Dunning Joins Qaelon Medical's Advisory Board to Enhance Surgical Leak Detection

Qaelon Medical Welcomes Dr. Joel Dunning

Qaelon Medical has announced an exciting new development in surgical technology by welcoming Dr. Joel Dunning to its Scientific Advisory Board. This appointment is poised to enhance the company's pioneering work in real-time surgical leak detection and advanced insufflation technology.

Dr. Dunning, a distinguished thoracic surgeon, brings a wealth of expertise and innovation to Qaelon. He has a notable background in minimally invasive and robotic surgery, specializing in techniques that lessen patient recovery time and improve surgical outcomes. As a leader in the field, Dr. Dunning will help steer the clinical development of Qaelon's groundbreaking platform, which is designed for real-time detection and localization of surgical leaks. This is particularly relevant for procedures involving minimally invasive approaches.

Eran Shlomovitz, MD, the Chief Medical Officer and Founder of Qaelon Medical, expressed enthusiasm about Dr. Dunning's joining the team, stating, "His global leadership and expertise in thoracic surgery, along with his track record of advancing breakthrough technologies, will be invaluable as we fine-tune our technology to detect and precisely pinpoint surgical leaks during complex procedures."

Having graduated from Oxford University and earned a PhD from Manchester University, Dr. Dunning's credentials are impressive. He is currently a thoracic surgeon at James Cook University Hospital in the UK and has been pivotal in training surgical teams on robotic techniques for Intuitive and Cambridge Medical Robotics. Additionally, he serves as the Editor in Chief for CTSNet and has published numerous influential guidelines throughout his career, affecting global standards in cardiothoracic surgery.

Moreover, Dr. Dunning has been actively involved in humanitarian efforts, leading heart surgery missions to Ghana since 2019 and overseeing the Pace4life charity, which has facilitated the implantation of over 200 reconditioned pacemakers in the past year.

In his own words, Dr. Dunning stated, "I am honored to join Qaelon's Scientific Advisory Board. I look forward to guiding the development of their real-time leak detection and precise leak localization technologies. Prolonged air leaks remain one of the most challenging aspects of thoracic surgery, and Qaelon's real-time, quantifiable data aligns perfectly with the shift toward less invasive surgical approaches. I am excited to collaborate with other members of the Advisory Board to improve patient outcomes using the innovative technology developed by Qaelon."

Liam Burns, the CEO of Qaelon Medical, shared the company's ambition: "We aim to revolutionize surgical practices by making real-time leak detection and localization an essential, data-driven component of every minimally invasive procedure. Under the guidance of experts like Dr. Dunning, we're moving from reactive safeguards to proactive insights, pushing surgical care into the digital age and establishing new benchmarks for safety and effectiveness."

Qaelon Medical’s approach to surgical leak detection is set to redefine patient care standards. Their platform combines real-time, AI-assisted leak detection with advanced, constant-flow insufflation, significantly enhancing the surgical workflow. By integrating digital sensors and advanced algorithms, Qaelon enables intraoperative interventions that could reduce complications, shorten hospital stays, and lower healthcare costs.

Though still under development and awaiting FDA clearance for market introduction in both the United States and Europe, Qaelon Medical's innovations promise to transform the landscape of minimally invasive surgery.

For further details, please check Qaelon Medical’s website at www.qaelonmedical.com or reach out to Yee Ying Douchamps at [email].